Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Buvidal 96mg/0.27ml prolonged-release inj pf syringes
0410030A0BGAFAT
|
Buvidal | Buprenorphine hydrochloride | Central Nervous System | 2,705 |
|
Buvidal 64mg/0.18ml prolonged-release inj pf syringes
0410030A0BGAEAS
|
Buvidal | Buprenorphine hydrochloride | Central Nervous System | 2,245 |
|
Buvidal 128mg/0.36ml prolonged-release inj pf syringes
0410030A0BGAGAU
|
Buvidal | Buprenorphine hydrochloride | Central Nervous System | 1,613 |
|
Buvidal 24mg/0.48ml prolonged-release inj pf syringes
0410030A0BGACAQ
|
Buvidal | Buprenorphine hydrochloride | Central Nervous System | 419 |
|
Buvidal 16mg/0.32ml prolonged-release inj pf syringes
0410030A0BGABAP
|
Buvidal | Buprenorphine hydrochloride | Central Nervous System | 368 |
|
Buvidal 8mg/0.16ml prolonged-release inj pf syringes
0410030A0BGAAAN
|
Buvidal | Buprenorphine hydrochloride | Central Nervous System | 235 |
|
Buvidal 160mg/0.45ml prolonged-release inj pf syringes
0410030A0BGAHAV
|
Buvidal | Buprenorphine hydrochloride | Central Nervous System | 208 |
|
Buvidal 32mg/0.64ml prolonged-release inj pf syringes
0410030A0BGADAR
|
Buvidal | Buprenorphine hydrochloride | Central Nervous System | 184 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.